Tag: G6PD deficiency

Higher-dose primaquine halves P. vivax recurrence in Indonesia, but safety trade-offs emerge

A meta-analysis of Indonesian data shows that doubling the primaquine dose from 3.5 mg/kg to 7 mg/kg halves P. vivax…

Ethiopia Study Reveals Stakeholder Concerns Over Novel Malaria Treatments

A qualitative study in Ethiopia reveals that health workers and patients view shorter-course malaria treatments as promising but harbour significant…

Point-of-care G6PD testing safely enables primaquine treatment for vivax malaria in Southeast Asia

A safety study in The Lancet Regional Health demonstrates that point-of-care G6PD testing can safely guide primaquine treatment for vivax…

Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network